Real World Data and Technology Bring Chronic Wound Research into the Limelight

Real World Data and Technology Bring Chronic Wound Research into the Limelight

The latest research findings for cancer, heart disease, and diabetes perpetually grab the spotlight, but now, under-the-radar conditions, such as non-healing chronic wounds, are being recognized. Considering that they affect millions of Americans, including approximately 8.2 million Medicare beneficiaries1, with projected annual costs ranging from $28.1 to $96.8 billion, this condition deserves attention. Recently, the…

Net Health Resources Page, white paper, blue image

The Dos & Don’ts of Clinical Trial Participant Retention

Imagine you spent weeks planning for a great party. The food, entertainment, and decorations were all carefully thought-out, and everything was in place for a great event. Lots of people showed up; then, everyone started to leave, just as things were getting good.  Clinical trial sponsors know just how that party host feels. Participants dropping…

Looking for better RWD Insights? Here are some new sources to consider

Looking for better RWD Insights? Here are some new sources to consider

Real-World Data (RWD) is having a moment.  Clinical trial sponsors, investigators, regulators, and payers are embracing this powerful addition to clinical research, which offers critical insight into how patients use products in the real world.  What is RWD?  Randomized controlled trials (RCTs) remain the gold standard for evaluating the safety and efficacy of an investigational…

Net Health Names Keith Tode VP of Clinical Research

Net Health Names Keith Tode VP of Clinical Research

Experienced veteran will help company further build its rapidly growing Tissue Analytics Division Pittsburgh, PA – March 10, 2022 – Highlighting the vital role wound and tissue clinical research will play in the industry and for the company, Net Health announced today the appointment of Keith Tode, MBA as the new Vice President of Clinical…